Prescribing pattern of psychotropic drugs in nursing home residents with dementia. (Q51003923)

26 March 2018

title

Prescribing pattern of psychotropic drugs in nursing home residents with dementia. (English)

1 reference

26 March 2018

0 references

R B Wetzels

1

1 reference

26 March 2018

S U Zuidema

2

1 reference

26 March 2018

J F M de Jonghe

3

1 reference

26 March 2018

F R J Verhey

4

1 reference

26 March 2018

R T C M Koopmans

5

1 reference

26 March 2018

publication date

20 June 2011

1 reference

26 March 2018

International Psychogeriatrics

published in

1 reference

26 March 2018

volume

23

1 reference

26 March 2018

issue

8

1 reference

26 March 2018

page(s)

1249-1259

1 reference

26 March 2018

Psychotropic drug use in a group of Dutch nursing home patients with dementia: many users, long-term use, but low doses.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch nursing home version of the neuropsychiatric inventory in different stages of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Agitation in Dutch institutionalized patients with dementia: factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Meta-analysis of the impact of 9 medication classes on falls in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Validity of the Severe Impairment Battery Short Version

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Development of a short form of the Severe Impairment Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Nursing home physicians' knowledge of and attitudes toward nonpharmacological interventions for treatment of behavioral disturbances associated with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Unexplained variation across US nursing homes in antipsychotic prescribing rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Management of agitation and aggression associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Long term care staff beliefs about evidence based practices for the management of dementia and agitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Impact of FDA black box advisory on antipsychotic medication use

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioral symptoms associated with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Survey of neuroleptic prescribing in residents of nursing homes in Glasgow

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

The challenge of looking after people with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Guidelines for the management of agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

Development of a Short Form of the Severe Impairment Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

Medication use in nursing homes for elderly people.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

Factors associated with psychotropic drug usage among nursing home residents with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000755

7 January 2021

10.1017/S1041610211000755

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018